• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

早期使用阿片类药物控制头颈癌患者放疗所致疼痛的优势。

Advantage of early induction of opioid to control pain induced by irradiation in head and neck cancer patients.

作者信息

Takase Hisamitsu, Sakata Toshifumi, Yamano Takafumi, Sueta Takayuki, Nomoto Satoshi, Nakagawa Takashi

机构信息

Department of Pharmacy, Fukuoka University Hospital, Japan.

出版信息

Auris Nasus Larynx. 2011 Aug;38(4):495-500. doi: 10.1016/j.anl.2010.12.012. Epub 2011 Jan 31.

DOI:10.1016/j.anl.2010.12.012
PMID:21277720
Abstract

OBJECTIVE

Although radiotherapy is effective for head and neck cancer patients, the local pain evoked by the irradiation itself reduces food intake and frequently halts the treatment. Thus, pain control is an important problem in radiotherapy for head and neck cancer. We performed to examine whether early induction of low-dose, opioid from mild pain improves dietary and caloric intake, while reducing weight loss.

METHODS

The subjects were 43 patients who were hospitalized for head and neck cancer from 2004 to 2008. They were patients who underwent radiation treatment but those who did not undergo preoperative treatment. They were divided into two groups, depending on whether the pain was mild or moderate when an opioid was introduced (MILD and MODERATE, N=23 and 20, respectively).

RESULTS

The visual analog scale scores for pain were significantly lower in the MILD than in the MODERATE group at between 25 and 50 Gy. The amount of oxycodone used for pain was significantly lower in the MILD than the MODERATE group. A regular diet was maintained for significantly longer in the MILD group. Caloric intake was significantly higher in the MILD group at over 20 Gy. Weight loss was significantly lower in the MILD group at over 20 Gy. The incidence of side effects was equal in both groups.

CONCLUSION

Our results indicated that the introduction of opioids for mild pain during radiotherapy controls the level of pain, improving food intake in head and neck cancer patients.

摘要

目的

尽管放射治疗对头颈部癌患者有效,但放疗本身引发的局部疼痛会减少食物摄入量,并常常导致治疗中断。因此,疼痛控制是头颈部癌放射治疗中的一个重要问题。我们进行了研究,以检验在轻度疼痛时早期引入低剂量阿片类药物是否能改善饮食和热量摄入,同时减少体重减轻。

方法

研究对象为2004年至2008年因头颈部癌住院的43例患者。他们均接受了放射治疗,但未接受术前治疗。根据引入阿片类药物时疼痛为轻度还是中度,将他们分为两组(轻度组和中度组,分别为N = 23和20)。

结果

在25至50 Gy之间,轻度组的疼痛视觉模拟量表评分显著低于中度组。轻度组用于止痛的羟考酮用量显著低于中度组。轻度组维持正常饮食的时间显著更长。在超过20 Gy时,轻度组的热量摄入显著更高。在超过20 Gy时,轻度组的体重减轻显著更低。两组的副作用发生率相同。

结论

我们的结果表明,在放疗期间对轻度疼痛引入阿片类药物可控制疼痛程度,改善头颈部癌患者的食物摄入量。

相似文献

1
Advantage of early induction of opioid to control pain induced by irradiation in head and neck cancer patients.早期使用阿片类药物控制头颈癌患者放疗所致疼痛的优势。
Auris Nasus Larynx. 2011 Aug;38(4):495-500. doi: 10.1016/j.anl.2010.12.012. Epub 2011 Jan 31.
2
Efficacy and tolerability of cancer pain management with controlled-release oxycodone tablets in opioid-naive cancer pain patients, starting with 5 mg tablets.起始剂量为5毫克片剂的控释羟考酮片用于初用阿片类药物的癌症疼痛患者癌痛管理的疗效和耐受性
Jpn J Clin Oncol. 2004 Oct;34(10):608-14. doi: 10.1093/jjco/hyh104.
3
Analgesic efficacy of controlled-release oxycodone in patients with uterine or ovarian cancer.控释羟考酮对子宫癌或卵巢癌患者的镇痛效果。
Am J Ther. 2008 Jan-Feb;15(1):31-5. doi: 10.1097/01.MJT.0000249928.97210.29.
4
Transdermal fentanyl for pain caused by radiotherapy in head and neck cancer patients treated in an outpatient setting: a multicenter trial in Taiwan.门诊治疗头颈部癌症患者放疗所致疼痛的经皮芬太尼:台湾的一项多中心试验。
Jpn J Clin Oncol. 2010 Apr;40(4):307-12. doi: 10.1093/jjco/hyp166. Epub 2009 Dec 30.
5
Opioid switch in palliative care, opioid choice by clinical need and opioid availability.姑息治疗中的阿片类药物转换、根据临床需求选择阿片类药物以及阿片类药物的可及性。
Eur J Pain. 2005 Oct;9(5):571-9. doi: 10.1016/j.ejpain.2004.12.003. Epub 2005 Jan 20.
6
Use of oxycodone in polytrauma patients: the "Gemelli" experience.多创伤患者中羟考酮的使用:“杰梅利”经验
Eur Rev Med Pharmacol Sci. 2008 Mar-Apr;12(2):123-6.
7
Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma.局部应用吗啡对头颈部癌同步放化疗后黏膜炎相关疼痛的影响。
Cancer. 2002 Nov 15;95(10):2230-6. doi: 10.1002/cncr.10938.
8
Postmarketing surveillance study of OxyContin tablets for relieving moderate to severe cancer pain.奥施康定片缓解中度至重度癌痛的上市后监测研究。
Oncology. 2008;74 Suppl 1:46-51. doi: 10.1159/000143218. Epub 2008 Aug 28.
9
Don't overlook directions.不要忽视说明。
Am J Nurs. 1996 Dec;96(12):14-5.
10
[New study demonstrates dual effect of an oxycodone/naloxone combination. Strong pain palliation and preserving intestinal function].[新研究证明羟考酮/纳洛酮组合的双重作用。强效缓解疼痛并保留肠道功能]
MMW Fortschr Med. 2007 Nov 29;149(48):50.

引用本文的文献

1
A pharmacist-led opioid de-escalation program after completion of chemoradiotherapy in locally advanced head and neck cancer.在局部晚期头颈癌患者完成放化疗后,由药剂师主导的阿片类药物减量计划。
Front Oncol. 2023 Sep 15;13:1145323. doi: 10.3389/fonc.2023.1145323. eCollection 2023.
2
Opioid therapy vs. multimodal analgesia in head and neck Cancer (OPTIMAL-HN): study protocol for a randomized clinical trial.阿片类药物治疗与头颈部癌症的多模式镇痛(OPTIMAL-HN):一项随机临床试验的研究方案。
BMC Palliat Care. 2021 Mar 19;20(1):45. doi: 10.1186/s12904-021-00735-0.
3
The association between cumulative radiation dose and the incidence of severe oral mucositis in head and neck cancers during radiotherapy.
放疗中累积辐射剂量与头颈部癌症重度口腔黏膜炎发生率的关系。
Cancer Rep (Hoboken). 2021 Apr;4(2):e1317. doi: 10.1002/cnr2.1317. Epub 2020 Dec 9.
4
Role of Oxycodone Hydrochloride in Treating Radiotherapy-Related Pain.盐酸羟考酮在治疗放疗相关疼痛中的作用。
Pain Res Manag. 2020 Jan 30;2020:7565962. doi: 10.1155/2020/7565962. eCollection 2020.
5
Is pain part of a systemic syndrome in head and neck cancer?头颈部癌症的疼痛是否属于全身综合征的一部分?
Support Care Cancer. 2020 Feb;28(2):451-459. doi: 10.1007/s00520-019-05147-8. Epub 2019 Nov 12.
6
Efficacy of controlled-release oxycodone for reducing pain due to oral mucositis in nasopharyngeal carcinoma patients treated with concurrent chemoradiotherapy: a prospective clinical trial.控释羟考酮缓解同期放化疗鼻咽癌患者口腔黏膜炎疼痛的疗效:一项前瞻性临床试验。
Support Care Cancer. 2019 Oct;27(10):3759-3767. doi: 10.1007/s00520-019-4643-5. Epub 2019 Feb 2.
7
A systematic review of the risk factors for clinical response to opioids for all-age patients with cancer-related pain and presentation of the paediatric STOP pain study.癌症相关疼痛的所有年龄段患者对阿片类药物临床反应的风险因素的系统评价及儿科 STOP 疼痛研究介绍。
BMC Cancer. 2018 May 18;18(1):568. doi: 10.1186/s12885-018-4478-3.